A cohort study on Bevacizumab in patients with advanced non-small-cell lung cancer excluding squamous cell lung cancer

A cohort study on Bevacizumab in patients with advanced non-small-cell lung cancer excluding squamous cell lung cancer - A cohort study on Bevacizumab in patients with advanced non-small-cell lung cancer excluding squamous cell lung cancer

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007215

Enrollment

120

Registered

2012-02-02

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small-cell lung cancer(Excluding squamous call lung cancer)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who received bevacizumab containing chemotherapy.

Exclusion criteria

Exclusion criteria: none.

Design outcomes

Primary

Measure	Time frame
Efficacy and safety(Time to Treatment Failure)	—

Secondary

Measure	Time frame
Individual side effect and efficacy,Response rate,Overall survival	—

Countries

Japan

Contacts

Public ContactYoichi Nakamura

Nagasaki University Hospital Second department of internal medicine

yi-nakamu@umin.ac.jp0958197273

Outcome results